Insiders · ALLK

Dolca Thomas

Director at Allakos Inc. (ALLK) since July 2023

Dolca Thomas has filed 9 insider reports with the SEC since June 2021, as director at Allakos Inc. (ALLK) and director at Chinook Therapeutics, Inc. (KDNY). Dolca Thomas made no open-market purchases or sales in the last 12 months. The latest filing, on May 15, 2025, reports sale back to the company at Allakos Inc. (ALLK).

Filings
9
Companies
2
Bought on market
$212K
Sold on market
None

Companies where Dolca Thomas is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Allakos Inc. logo
ALLK
Allakos Inc.
Directorsince July 2023May 15, 2025
Chinook Therapeutics, Inc. logo
KDNY
Chinook Therapeutics, Inc.
Director0$212K$21.22Aug 11, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Dolca Thomas with

Other insiders at the same companies

Questions about Dolca Thomas

What is Dolca Thomas's role at Allakos Inc.?
Dolca Thomas reports to the SEC as director at Allakos Inc. (ALLK), according to the latest filing on May 15, 2025. Dolca Thomas has also filed as director at Chinook Therapeutics, Inc. (KDNY).
Has Dolca Thomas bought or sold stock recently?
The most recent open-market purchase was on September 2, 2022: bought 10,000 shares of Chinook Therapeutics, Inc. (KDNY) for $212K at an average of $21.22.
How do I get alerts when Dolca Thomas files?
Follow Dolca Thomas on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Dolca Thomas (SEC CIK 0001768239). Totals count each trade once, skipping amendments whose original is on file, from Jun 8, 2021 on. View on SEC EDGAR · Get this as JSON